| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.14 | 0.3 |